This article is rated Start-class on Wikipedia's content assessment scale. |
Matrix-M seems to be just a trademark for a specific patented ISCOM. Liebeskind (talk) 15:55, 4 September 2022 (UTC)
- Oppose; just as not all COVID vaccines are on one page, so too it seems reasonable to keep Matrix-M separate. The clinical trials related to that product, and can't be generalize to all ISCOMs. Klbrain (talk) 20:55, 15 April 2023 (UTC)
- Closing, given the uncontested objection and no support. Klbrain (talk) 08:12, 15 July 2023 (UTC)